Sacituzumab govitecan for Breast Cancer User Reviews
Brand names: Trodelvy
- Stage...
- Taken for 1 to 6 months
- April 24, 2024
Trodelvy (sacituzumab govitecan) "Horrible paralyzing bone pain. Horrible constipation or diarrhea. Horrible experience. Also, face numbness."
- Elle...
- February 5, 2024
Trodelvy (sacituzumab govitecan) "Other than neutropenia and alopecia, my side effects are minimal. I'm in the middle of my treatment plan, still hopeful that this will give me a sustained remission."
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
Learn more about Breast Cancer
- Breast Cancer Guide
- Breast Cancer: Treatment and Prevention Options
- Cancer Center
- FDA-Approved Weight Loss Drugs: Can They Help You?
Care guides
Symptoms and treatments
Medicine.com guides (external)
More about sacituzumab govitecan
- Check interactions
- Compare alternatives
- Reviews (3)
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
Trodelvy (sacituzumab govitecan) "I occasionally have slurred speech and difficulty swallowing. It's kind of intermittent. No other side effect except complete alopecia"